Home Cart Sign in  
Chemical Structure| 2100284-59-9 Chemical Structure| 2100284-59-9

Structure of AZ3451
CAS No.: 2100284-59-9

Chemical Structure| 2100284-59-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

AZ3451 is a protease-activated receptor-2 (PAR2) antagonist.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of AZ3451

CAS No. :2100284-59-9
Formula : C30H27BrN4O3
M.W : 571.46
SMILES Code : O=C(C1=CC=C2C(N=C(C3=C(Br)C=C(OCO4)C4=C3)N2[C@H](C5CCCCC5)C)=C1)NC6=CC=C(C#N)C=C6
MDL No. :MFCD31728469
InChI Key :FJAOGFGHTPYADT-SFHVURJKSA-N
Pubchem ID :126961335

Safety of AZ3451

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of AZ3451

GPCR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HUVEC cells 10 μM 1 hour To investigate the effect of AZ3451 on CHI3L1/PAR2 signaling in HUVEC cells, results showed AZ3451 attenuated AICAR-induced HUVEC tubule formation and upregulation of CHI3L1/PAR2. Biomedicines. 2022 Apr 29;10(5):1028
rat chondrocytes 10 μM 48 h AZ3451 suppressed IL-1β-induced inflammation response, cartilage degradation and premature senescence. Aging (Albany NY). 2019 Dec 16;11(24):12532-12545

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague Dawley rats Hyperuricemia model Intraperitoneal injection 1 mg/kg Daily for 6 weeks To evaluate the protective effect of AZ3451 on hyperuricemia-induced renal injury. Results showed that AZ3451 significantly attenuated tubular dilatation and tubulointerstitial inflammatory cell infiltration, reduced serum creatinine and BUN levels, and significantly decreased serum KIM-1 and NGAL levels. Mediators Inflamm. 2023 Jul 13;2023:5007488

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.75mL

0.35mL

0.17mL

8.75mL

1.75mL

0.87mL

17.50mL

3.50mL

1.75mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories